Psychiatry

Neuromodulation: Deep Brain Stimulation and Vagus Nerve Stimulation Devices Market

This chapter provides an overview of primary neurological diseases/disorders treated with deep brain stimulation (DBS) and vagus nerve stimulation (VNS), as well as overview of DBS and VNS neuromodulation technologies, competitors, sales, forecasts, competitive and market analysis. Markets covered by this analysis include the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world (RoW) markets.

May 8, 2020

Drug Delivery: Transdermal Devices

This comprehensive medical market and technology report provides a comprehensive discussion of transdermal drug delivery technology for the treatment of cardiovascular disease (CVD), neurological disorders, hormone replacement therapy (HRT), pain management, and genitourinary disorder management. Markets covered by this analysis include the US, Japan, the five major EU markets (France,Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets.

April 15, 2020

United Kingdom, Surgical Procedure Volumes

This report presents an overview of selected medical specialties and the number of surgical procedures performed for selected diseases/disorders in the European Union member state of the U.K.

France, Disease Incidence and Prevalence

As the aging population in Europe increases and the average life span lengthens, the incidence and prevalence of many major diseases/disorders are expected to increase accordingly and significantly impact the European healthcare industry.

U.S. Markets for Heart Valve Disorder Management Products

This comprehensive report examines the etiology and epidemiology, number of hospital discharges, incidence and prevalence, and mortality rates of the most prevalent diseases/disorders in the United States for the years 2000-2010, and 2013.

U.S. Neurostimulation Devices Market, June 2015

$5,250.00

An estimated 200 million people in the United States (U.S.) experience some degree of neurological impairment over the course of a lifetime.

Global Neurostimulation Devices Market, June 2016

The large and burgeoning global market for implantable neurostimulation devices is approaching nearly $4 billion worldwide. Despite lingering economic uncertainty and financial constraints that have affected many other medical device markets, this market is undergoing significant technological advancement due to heavy R&D and investment efforts by dozens of innovative startups and leading medical device companies.

June 1, 2016

Asia-Pacific Disease Incidence and Prevalence

$5,250.00

The Asia-Pacific (APAC) region is a part of the world which includes several developing and developed countries. Countries covered in this report include Australia, China, India, Japan, Malaysia, South Korea, Thailand, and Vietnam.

January 1, 2016

U.S. Surgical Procedure Volumes

This report presents the most common surgical procedures performed in the United States (U.S.) as well as an overview of the etiology and epidemiology of selected diseases/disorders, prevailing surgical approaches/techniques, and evolving procedural utilization trends.

November 1, 2015

Asia-Pacific: Surgical Procedure Volumes

$5,250.00

This report examines the healthcare trends in Asia-Pacific countries (Japan, China, South Korea, India, Thailand, Vietnam, Malaysia and Australia), as well as analyzes and forecasts (toward 2019).

September 1, 2015

Spain, Surgical Procedure Volumes

This report presents an overview of selected medical specialties and the number of surgical procedures performed for selected diseases/disorders in the European Union country of Spain.

November 1, 2013

Germany, Surgical Procedure Volumes

This report presents an overview of selected medical specialties and the number of surgical procedures performed for selected diseases/disorders in the European Union country of Germany.

October 1, 2013

France, Surgical Procedure Volumes

This report presents an overview of selected medical specialties and the number of surgical procedures performed for selected diseases/disorders in the EU country of France.

August 1, 2013